Stephen R. Davis J.D.
Net Worth

Last updated:

What is Stephen R. Davis J.D. net worth?

The estimated net worth of Mr. Stephen R. Davis J.D. is at least $61,115,982 as of 19 Aug 2024. He owns shares worth $4,658,278 as insider, has earned $49,077,704 from insider trading and has received compensation worth at least $7,380,000 in ACADIA Pharmaceuticals Inc..

What is the salary of Stephen R. Davis J.D.?

Mr. Stephen R. Davis J.D. salary is $1,230,000 per year as Chief Executive Officer & Director in ACADIA Pharmaceuticals Inc..

How old is Stephen R. Davis J.D.?

Mr. Stephen R. Davis J.D. is 64 years old, born in 1961.

What stocks does Stephen R. Davis J.D. currently own?

As insider, Mr. Stephen R. Davis J.D. owns shares in one company:

Company Title Shares Price per share Total value
ACADIA Pharmaceuticals Inc. (ACAD) Chief Executive Officer & Director 186,555 $24.97 $4,658,278

What does ACADIA Pharmaceuticals Inc. do?

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

ACAD logo
ACAD
ACADIA Pharmaceuticals Inc.
$24.97

Stephen R. Davis J.D. insider trading

ACADIA Pharmaceuticals Inc.

Mr. Stephen R. Davis J.D. has made 34 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 31,747 units of ACAD stock worth $485,094 on 19 Aug 2024.

The largest trade he's ever made was exercising 150,000 units of ACAD stock on 5 Dec 2019. As of 19 Aug 2024 he still owns at least 186,555 units of ACAD stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 31,747 $15.28 $485,094
Sale
Common Stock 11,427 $16.94 $193,573
Option
Restricted Stock Units 22,391 N/A N/A
Option
Common Stock 22,391 N/A N/A
Sale
Common Stock 8,858 $17.87 $158,292
Sale
Common Stock 17,716 $17.87 $316,585
Option
Common Stock 34,666 N/A N/A
Option
Common Stock 17,333 N/A N/A
Option
Restricted Stock Units 34,666 N/A N/A
Option
Restricted Stock Units 17,333 N/A N/A
Sale
Common Stock 17,714 $17.9 $317,081
Sale
Common Stock 5,577 $24.67 $137,585
Option
Common Stock 10,946 N/A N/A
Option
Restricted Stock Units 10,946 N/A N/A
Sale
Common Stock 3,732 $29.96 $111,811
Option
Restricted Stock Units 9,528 N/A N/A
Option
Common Stock 9,528 N/A N/A
Option
Restricted Stock Units 103,999 N/A N/A
Sale
Common Stock 51,563 $21.96 $1,132,323
Option
Common Stock 103,999 N/A N/A
Option
Common Stock 100,000 $20.77 $2,077,000
Sale
Common Stock 100,000 $30.04 $3,004,400
Option
Stock Option (Right to Buy) 100,000 $20.77 $2,077,000
Sale
Common Stock 55,104 $25.05 $1,380,465
Sale
Common Stock 16,498 $25 $412,450
Sale
Common Stock 7,806 $21.18 $165,331
Option
Restricted Stock Units 15,625 N/A N/A
Option
Common Stock 15,625 N/A N/A
Sale
Common Stock 8,582 $18.16 $155,849
Option
Restricted Stock Units 17,333 N/A N/A
Option
Common Stock 17,333 N/A N/A
Sale
Common Stock 3,851 $18.78 $72,322
Option
Restricted Stock Units 10,945 N/A N/A
Option
Common Stock 10,945 N/A N/A
Sale
Common Stock 3,904 $17.13 $66,876
Option
Common Stock 9,528 N/A N/A
Option
Restricted Stock Units 9,528 N/A N/A
Sale
Common Stock 2,804 $15.81 $44,331
Option
Restricted Stock Units 5,938 N/A N/A
Option
Common Stock 5,938 N/A N/A
Option
Restricted Stock Units 15,625 N/A N/A
Sale
Common Stock 5,483 $18.18 $99,692
Option
Common Stock 15,625 N/A N/A
Option
Restricted Stock Units 10,945 N/A N/A
Option
Common Stock 10,945 N/A N/A
Sale
Common Stock 3,928 $23.8 $93,486
Option
Restricted Stock Units 9,527 N/A N/A
Sale
Common Stock 3,718 $23.05 $85,700
Option
Common Stock 9,527 N/A N/A
Sale
Common Stock 2,963 $17.41 $51,586
Option
Restricted Stock Units 5,938 N/A N/A
Option
Common Stock 5,938 N/A N/A
Sale
Common Stock 7,850 $20.33 $159,591
Option
Restricted Stock Units 15,625 N/A N/A
Option
Common Stock 15,625 N/A N/A
Sale
Common Stock 14,195 $50.61 $718,409
Sale
Common Stock 3,484 $53.34 $185,837
Option
Restricted Stock Units 9,527 N/A N/A
Option
Common Stock 9,527 N/A N/A
Sale
Common Stock 2,960 $42.56 $125,978
Option
Common Stock 5,937 N/A N/A
Option
Restricted Stock Units 5,937 N/A N/A
Sale
Common Stock 88,542 $45.33 $4,013,786
Option
Common Stock 88,542 $19.65 $1,739,850
Option
Stock Option (Right to Buy) 88,542 $19.65 $1,739,850
Sale
Common Stock 88,542 $45.33 $4,013,786
Option
Common Stock 111,458 N/A N/A
Sale
Common Stock 111,458 $46.97 $5,234,959
Sale
Common Stock 111,458 $46.97 $5,234,959
Option
Stock Option (Right to Buy) 111,458 N/A N/A
Sale
Common Stock 6,770 $49.21 $333,152
Option
Restricted Stock Units 15,625 N/A N/A
Option
Common Stock 15,625 N/A N/A
Option
Common Stock 150,000 N/A N/A
Option
Stock Option (Right to Buy) 150,000 N/A N/A
Sale
Common Stock 150,000 $52.08 $7,811,550
Sale
Common Stock 150,000 $52.08 $7,811,550
Option
Common Stock 5,937 N/A N/A
Sale
Common Stock 2,983 $39.65 $118,276
Option
Restricted Stock Units 5,937 N/A N/A
Option
Common Stock 120,208 $40.19 $4,831,039
Sale
Common Stock 120,208 $40.19 $4,831,039
Option
Stock Option (Right to Buy) 120,208 $40.19 $4,831,039
Option
Stock Option (Right to Buy) 29,792 N/A N/A
Sale
Common Stock 29,792 N/A N/A
Option
Common Stock 29,792 N/A N/A

ACADIA Pharmaceuticals key executives

ACADIA Pharmaceuticals Inc. executives and other stock owners filed with the SEC: